The compound is not approved by any regulatory authority, and its safety or effectiveness in humans has not been established
The two peptides share a chain length but almost nothing else in terms of origin, receptor targets, or downstream signaling
Potential Side Effects and Safety Concerns Although the treatment is safe in medically supervised settings, mild side effects can happen, such as: Temporary redness or swelling at the injection site Slight dizziness or nausea Rare allergic reactions (rash, itching) Patients are advised to disclose any history of allergies or chronic illness before starting treatment
Semaglutide should not be used for the treatment of type 1 diabetes mellitus
Besides death, CLD causes severe damage to patients quality of life, as well as substantial medical and economic costs (Stepanova et al., 2017)
Quality product and excellent customer service